We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$11.3M 0.79%
36,549
-483
-1% -$141K
IBM icon
27
IBM
IBM
$213B
$11.1M 0.78%
96,044
+3,700
+4% +$430K
VZ icon
28
Verizon
VZ
$197B
$11M 0.77%
200,231
+3,150
+2% +$177K
UNP icon
29
Union Pacific
UNP
$174B
$10.9M 0.77%
64,705
+1,665
+3% +$267K
MCD icon
30
McDonald's
MCD
$193B
$10.3M 0.72%
55,772
-283
-0.5% -$51.9K
NKE icon
31
Nike
NKE
$64.1B
$10.2M 0.71%
103,607
+9,080
+10% +$838K
CL icon
32
Colgate-Palmolive
CL
$74.8B
$9.64M 0.68%
131,649
-400
-0.3% -$28.4K
UPS icon
33
United Parcel Service
UPS
$88.9B
$9.52M 0.67%
85,635
-12,904
-13% -$1.29M
TXN icon
34
Texas Instruments
TXN
$248B
$9.12M 0.64%
71,786
-1,972
-3% -$230K
ABT icon
35
Abbott
ABT
$187B
$9.11M 0.64%
99,590
-555
-0.6% -$50.2K
ETN icon
36
Eaton
ETN
$141B
$8.84M 0.62%
101,042
-1,028
-1% -$84.6K
PFE icon
37
Pfizer
PFE
$143B
$8.4M 0.59%
270,879
+1,893
+0.7% +$64.3K
XOM icon
38
ExxonMobil
XOM
$650B
$8.23M 0.58%
184,043
-5,065
-3% -$227K
MDT icon
39
Medtronic
MDT
$112B
$8.17M 0.57%
89,089
+550
+0.6% +$52.7K
GIS icon
40
General Mills
GIS
$20.2B
$8.15M 0.57%
132,202
+900
+0.7% +$54.3K
MMM icon
41
3M
MMM
$91.8B
$7.83M 0.55%
60,061
-1,931
-3% -$243K
CVS icon
42
CVS Health
CVS
$135B
$7.56M 0.53%
116,346
-527
-0.5% -$33.2K
RTX icon
43
RTX Corp
RTX
$290B
$7.51M 0.53%
121,814
-45,783
-27% -$2.86M
MRK icon
44
Merck
MRK
$322B
$7.49M 0.53%
101,557
-11,864
-10% -$893K
ORCL icon
45
Oracle
ORCL
$339B
$7.45M 0.52%
134,697
+101,209
+302% +$5.36M
GILD icon
46
Gilead Sciences
GILD
$165B
$7.38M 0.52%
95,964
+583
+0.6% +$44.7K
FISV
47
Fiserv Inc
FISV
$29.7B
$7.37M 0.52%
75,500
+10,842
+17% +$1.09M
TJX icon
48
TJX Companies
TJX
$179B
$7.27M 0.51%
143,751
-2,050
-1% -$103K
PLD icon
49
Prologis
PLD
$136B
$7.08M 0.5%
75,826
+52,426
+224% +$4.68M
DE icon
50
Deere & Co
DE
$165B
$7.04M 0.49%
44,780
+3,495
+8% +$506K
1
2
3 4 5

Similar funds

HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.